Yellowing of the eyes (scleral icterus) - Causes, Treatment & When to See a Doctor

```html

What is Yellowing of the eyes (scleral icterus)?

Scleral icterus, commonly described as the yellowing of the white part of the eye (the sclera), is a visible sign that a substance called bilirubin is building up in the bloodstream. Bilirubin is a yellow‑pigmented by‑product formed when red blood cells break down. Under normal conditions the liver processes bilirubin and eliminates it in the stool. When this pathway is disrupted, bilirubin accumulates and deposits in fat‑soluble tissues—including the sclera—producing a characteristic golden or amber tint.

Unlike a fleeting “red eye” caused by irritation or infection, scleral icterus usually indicates a systemic issue. It may appear within a few days of rising bilirubin levels and is often one of the first signs that a liver‑related problem is developing.

Common Causes

Many disorders can lead to elevated bilirubin and scleral icterus. The most frequent are:

• Hepatitis (viral, alcoholic, autoimmune) – Inflammation impairs liver cells’ ability to conjugate and excrete bilirubin.
• Cirrhosis – Chronic scarring reduces functional liver mass, limiting bilirubin processing.
• Gallstones or Biliary obstruction – Blockage of the bile ducts prevents bilirubin from entering the intestine.
• Hemolytic anemia – Accelerated red‑cell destruction releases excess unconjugated bilirubin.
• Genetic disorders (e.g., Gilbert’s syndrome, Crigler‑Najjar syndrome) – Enzyme deficiencies affect bilirubin conjugation.
• Drug‑induced liver injury – Acetaminophen overdose, certain antibiotics, antiepileptics, and herbal supplements can damage hepatocytes.
• Pancreatic cancer or cholangiocarcinoma – Tumors compress the bile duct, causing cholestasis.
• Sepsis or severe infection – Can cause cholestatic liver dysfunction.
• Newborn physiologic jaundice – Immature liver enzymes in infants lead to temporary bilirubin rise; usually resolves in 1–2 weeks.
• Alcoholic liver disease – Repeated heavy drinking causes fatty change, inflammation, and eventually cirrhosis.

Associated Symptoms

The presence of scleral icterus often accompanies other signs that point to the underlying cause. Commonly reported symptoms include:

• Yellowing of the skin (cutaneous jaundice), especially on the face and abdomen.
• Dark urine (bilirubin excreted in urine).
• Pale, clay‑colored stools (lack of bile pigments).
• Abdominal pain or fullness, particularly in the right upper quadrant.
• Pruritus (itchy skin) caused by bile salts depositing in the skin.
• Fatigue, weakness, or unintentional weight loss.
• Fever or chills if infection is present.
• Swelling of the abdomen (ascites) or legs (edema) in advanced liver disease.
• Confusion or altered mental status (hepatic encephalopathy) in severe liver failure.

When to See a Doctor

Because scleral icterus signals a problem with bilirubin clearance, prompt medical evaluation is important. Seek care if you notice any of the following:

• The yellow tint is new or worsening, especially if it spreads to the skin.
• Dark urine or light‑colored stools develop.
• Persistent abdominal pain, especially under the ribcage on the right side.
• Unexplained fever, chills, or flu‑like symptoms.
• Itchy skin that interferes with sleep or daily activities.
• Swelling of the abdomen or legs.
• Confusion, drowsiness, or difficulty concentrating.
• History of liver disease, chronic alcohol use, recent medication changes, or exposure to hepatitis viruses.

Diagnosis

Doctors combine a thorough history, physical exam, and targeted testing to determine why bilirubin is elevated.

History & Physical Examination

• Ask about alcohol intake, medication use (prescription, over‑the‑counter, herbal), recent travel, sexual history, and family history of liver disease.
• Inspect the sclera and skin, palpate the abdomen for liver size, tenderness, or masses, and check for ascites.

Laboratory Tests

• Complete blood count (CBC) – Detects anemia or infection.
• Liver function panel – Includes AST, ALT, alkaline phosphatase (ALP), γ‑glutamyl transferase (GGT), and total & direct bilirubin.
• Coagulation studies (PT/INR) – Assess liver synthetic function.
• Serum albumin – Low in chronic liver disease.
• Viral hepatitis serologies – Hepatitis A, B, C antibodies or antigens.
• Autoimmune markers – ANA, ASMA, anti‑LKM1 for autoimmune hepatitis.
• Hemolysis work‑up – LDH, haptoglobin, reticulocyte count, peripheral smear.

Imaging Studies

• Ultrasound – First‑line to assess liver texture, gallbladder stones, bile‑duct dilation.
• CT or MRI abdomen – Provides detailed anatomy when tumors or complex disease are suspected.
• MRCP (magnetic resonance cholangiopancreatography) – Non‑invasive view of bile ducts.
• Endoscopic Retrograde Cholangiopancreatography (ERCP) – Diagnostic and therapeutic for certain obstructions.

Special Tests

• Liver biopsy – Considered when the cause remains unclear after non‑invasive studies.
• Genetic testing – For suspected hereditary bilirubin metabolism disorders.

Treatment Options

Treatment targets the underlying cause; the yellowing itself usually resolves once bilirubin levels fall.

General Measures

• Hydration – Adequate fluid intake helps renal excretion of bilirubin metabolites.
• Balanced diet – Emphasize protein, fruits, vegetables, and limit saturated fats and simple sugars.
• Avoid alcohol and hepatotoxic drugs until the cause is clarified.

Cause‑Specific Therapies

• Viral hepatitis – Antiviral regimens (e.g., sofosbuvir/velpatasvir for HCV, tenofovir or entecavir for HBV). Vaccination against hepatitis A and B if not immune.
• Hemolytic anemia – Treat the trigger (e.g., discontinue offending drug, manage autoimmune hemolysis with steroids or rituximab).
• Biliary obstruction – Endoscopic stone extraction, stent placement, or surgical bypass.
• Cirrhosis decompensation – Beta‑blockers for portal hypertension, diuretics for ascites, lactulose or rifaximin for hepatic encephalopathy.
• Drug‑induced liver injury – Immediate cessation of the offending agent; monitor liver enzymes weekly.
• Genetic disorders – Gilbert’s syndrome often requires no treatment; Crigler‑Najjar may need phototherapy (neonates) or liver transplantation.
• Newborn jaundice – Phototherapy is the standard; exchange transfusion in severe cases.
• Pancreatic or biliary cancer – Multidisciplinary approach: surgery, chemotherapy, radiation, or palliative stenting.

Symptomatic Relief

• **Pruritus** – Cholestyramine, rifampin, or antihistamines may reduce itching.
• **Fatigue** – Energy‑conserving strategies and treatment of underlying anemia or sleep disturbances.

Prevention Tips

While not all causes are preventable, many lifestyle choices can lower the risk of developing liver‑related jaundice.

• Limit alcohol intake: No more than 1 drink per day for women, 2 for men (CDC guidelines).
• Maintain a healthy weight to reduce non‑alcoholic fatty liver disease (NAFLD).
• Vaccinate against hepatitis A and B.
• Practice safe sex and avoid sharing needles to prevent viral hepatitis.
• Use medications responsibly; follow dosing instructions and discuss liver‑safe alternatives with your clinician.
• Eat a diet rich in fiber, antioxidants, and omega‑3 fatty acids (e.g., fish, nuts, olive oil).
• Stay physically active – at least 150 minutes of moderate‑intensity exercise per week.
• Regular health check‑ups for people with known risk factors (e.g., diabetes, family history of liver disease).

Emergency Warning Signs

Key Take‑aways

Scleral icterus is more than a cosmetic issue; it is a visible clue that bilirubin metabolism is out of balance. Recognizing the sign, understanding its common causes, and knowing when to seek medical care can prevent progression to serious liver disease. Prompt evaluation—through blood tests, imaging, and sometimes biopsy—allows targeted treatment, ranging from antiviral therapy to surgical relief of bile‑duct obstruction. Lifestyle measures such as moderating alcohol, maintaining a healthy weight, and staying up‑to‑date on vaccinations further reduce the risk of future episodes.

For personalized advice, always discuss your symptoms with a qualified healthcare professional. The information above reflects current guidelines from reputable sources including the Mayo Clinic, CDC, NIH, WHO, and Cleveland Clinic.

```